Sio Capital Management, LLC Eli Lilly & CO Transaction History

Sio Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $6.71 Million - $7.76 Million	-45,901 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $6.26 Million - $7.54 Million	45,901 New	45,901 $7.54 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $6.23 Million - $7.16 Million	-82,363 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $2.11 Million - $2.49 Million	28,463 Added 52.81%	82,363 $6.37 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $4.42 Million - $4.74 Million	53,900	53,900 $4.55 Million

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.